KR100692720B1 - Ｍｒｉ용 망간 조성물 및 그의 이용방법 - Google Patents

Ｍｒｉ용 망간 조성물 및 그의 이용방법 Download PDF

Info

Publication number
KR100692720B1
KR100692720B1 KR1020017005278A KR20017005278A KR100692720B1 KR 100692720 B1 KR100692720 B1 KR 100692720B1 KR 1020017005278 A KR1020017005278 A KR 1020017005278A KR 20017005278 A KR20017005278 A KR 20017005278A KR 100692720 B1 KR100692720 B1 KR 100692720B1
Authority
KR
South Korea
Prior art keywords
manganese
delete delete
calcium
gluconate
ions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020017005278A
Other languages
English (en)
Korean (ko)
Other versions
KR20010103622A (ko
Inventor
세안피터알.
하니쉬필립피.
베세이아델알.
Original Assignee
이글 비젼 파마시티컬 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이글 비젼 파마시티컬 코포레이션 filed Critical 이글 비젼 파마시티컬 코포레이션
Publication of KR20010103622A publication Critical patent/KR20010103622A/ko
Application granted granted Critical
Publication of KR100692720B1 publication Critical patent/KR100692720B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
KR1020017005278A 1998-11-02 1999-10-26 Ｍｒｉ용 망간 조성물 및 그의 이용방법 Expired - Fee Related KR100692720B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/184,835 1998-11-02
US09/184,835 US5980863A (en) 1998-11-02 1998-11-02 Manganese compositions and methods for MRI

Publications (2)

Publication Number Publication Date
KR20010103622A KR20010103622A (ko) 2001-11-23
KR100692720B1 true KR100692720B1 (ko) 2007-03-09

Family

ID=22678556

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017005278A Expired - Fee Related KR100692720B1 (ko) 1998-11-02 1999-10-26 Ｍｒｉ용 망간 조성물 및 그의 이용방법

Country Status (12)

Country Link
US (1) US5980863A (enExample)
EP (1) EP1126785B1 (enExample)
JP (1) JP4763132B2 (enExample)
KR (1) KR100692720B1 (enExample)
CN (1) CN1325286A (enExample)
AT (1) ATE434406T1 (enExample)
AU (1) AU754294B2 (enExample)
CA (1) CA2349342C (enExample)
DE (1) DE69941029D1 (enExample)
NO (1) NO327611B1 (enExample)
NZ (1) NZ511592A (enExample)
WO (1) WO2000025671A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60316410T2 (de) * 2002-02-05 2008-06-19 Bristol-Myers Squibb Co. N-substituierte 3-hydroxy-4-pyridinone und diese enthaltende pharmazeutika
US6869591B2 (en) * 2002-03-26 2005-03-22 Barnes-Jewish Hospital Paramagnetic particles that provide improved relaxivity
JP4614281B2 (ja) * 2002-12-16 2011-01-19 ジーイー・ヘルスケア・アクスイェ・セルスカプ 磁気共鳴撮像方法並びに該方法に用いられる化合物
US20050106100A1 (en) * 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
US20050197614A1 (en) * 2004-03-04 2005-09-08 Wilson Pritchard Occlusive biomedical devices, punctum plugs, and methods of use thereof
JP2006282604A (ja) * 2005-04-01 2006-10-19 Fuji Photo Film Co Ltd 金属キレート構造を有するグリセリンエステル誘導体
JP2009500410A (ja) * 2005-06-30 2009-01-08 ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー イメージング剤としてのヒドラジドコンジュゲート
US20080081021A1 (en) * 2006-09-29 2008-04-03 Mehmet Bilgen Manganese-enhanced magnetic resonance imaging of neurons using electrical stimulation
US8414866B2 (en) * 2007-12-17 2013-04-09 Ge Healthcare As Method of magnetic resonance imaging of the heart with paramagnetic MN2+
WO2011003818A2 (en) 2009-07-06 2011-01-13 Cmc Contrast Ab Diagnostic method
CN103656690B (zh) * 2012-09-11 2016-04-27 南京逐陆医药科技有限公司 一种氯化锰口服溶液的制备方法
KR101683635B1 (ko) 2014-12-29 2016-12-09 가천대학교 산학협력단 락테이트 금속염을 포함하는 암 치료용 약학 조성물
US10233205B2 (en) 2015-08-07 2019-03-19 Auburn University Magnetic resonance imaging contrast agent capable of detecting hydrogen peroxide and reducing reactive oxygen species
KR102868782B1 (ko) 2018-01-12 2025-10-13 (주)메티메디제약 만성 염증성 질환의 치료 방법
JP2020069470A (ja) * 2018-10-29 2020-05-07 株式会社げんてん本店 リポソームの製造方法、及び、リポソーム含有液の製造方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344640A (en) * 1991-10-22 1994-09-06 Mallinckrodt Medical, Inc. Preparation of apatite particles for medical diagnostic imaging

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1965535A (en) * 1933-03-01 1934-07-03 Pfizer Charles & Co Stable calcium gluconate solution and process of making same
FR2126134A1 (en) * 1971-02-26 1972-10-06 Ates Ibrahim Cyclophosphamide/magnesium compsns - with enhanced cytostatic activity
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3316703A1 (de) * 1983-05-04 1984-11-08 Schering AG, 1000 Berlin und 4709 Bergkamen Orales kontrastmittel fuer die kernspintomographie und dessen herstellung
SE465907B (sv) * 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall
US5082649A (en) * 1987-06-30 1992-01-21 Mallinckrodt Medical, Inc. Method for enhancing the safety of metal-ligand chelates as magnetic resonance imaging agents by addition of calcium ions
US4915933A (en) * 1986-06-26 1990-04-10 The University Of New Mexico Mixed complexes as shift and contrast reagents in NMR imaging and spectroscopy
AU608759B2 (en) * 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
NO884225L (no) * 1987-09-25 1989-03-28 Salutar Inc Nmr-bildedannelse mn(ii)- koordinasjonsforbindelser.
US5078986A (en) * 1989-02-15 1992-01-07 Mallinckrodt Medical, Inc. Method for enhancing magnetic resonance imaging using an image altering agent containing an excess of chelating agent
US5143716A (en) * 1991-02-01 1992-09-01 Unger Evan C Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
US5330742A (en) * 1991-08-05 1994-07-19 Mallinckrodt Medical, Inc. Methods and compositions for magnetic resonance imaging
US5250284A (en) * 1991-10-15 1993-10-05 Arnon Krongrad Method for increasing nuclear magnetic resonance signals in living biological tissue using zinc
JP2911674B2 (ja) * 1992-02-20 1999-06-23 明治乳業株式会社 消化管造影用組成物
US5401492A (en) * 1992-12-17 1995-03-28 Sterling Winthrop, Inc. Water insoluble non-magnetic manganese particles as magnetic resonance contract enhancement agents
GB9416768D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
AU688565B2 (en) * 1994-08-18 1998-03-12 Nycomed Imaging As Compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344640A (en) * 1991-10-22 1994-09-06 Mallinckrodt Medical, Inc. Preparation of apatite particles for medical diagnostic imaging

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
미국공개특허 제5,219.553호. *

Also Published As

Publication number Publication date
NZ511592A (en) 2002-09-27
AU1808600A (en) 2000-05-22
WO2000025671A9 (en) 2000-10-26
NO327611B1 (no) 2009-08-31
JP4763132B2 (ja) 2011-08-31
CA2349342A1 (en) 2000-05-11
AU754294B2 (en) 2002-11-14
EP1126785A4 (en) 2006-05-17
JP2002528473A (ja) 2002-09-03
ATE434406T1 (de) 2009-07-15
EP1126785A1 (en) 2001-08-29
CN1325286A (zh) 2001-12-05
DE69941029D1 (de) 2009-08-06
NO20011946L (no) 2001-04-19
EP1126785B1 (en) 2009-06-24
CA2349342C (en) 2011-07-12
NO20011946D0 (no) 2001-04-19
US5980863A (en) 1999-11-09
WO2000025671A1 (en) 2000-05-11
KR20010103622A (ko) 2001-11-23

Similar Documents

Publication Publication Date Title
KR100692720B1 (ko) Ｍｒｉ용 망간 조성물 및 그의 이용방법
Ferrucci et al. Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years.
Schoenberg et al. Quantification of renal perfusion abnormalities using an intravascular contrast agent (part 2): results in animals and humans with renal artery stenosis
JPH05506793A (ja) 磁気共鳴造影の改良およびその関連技術
Roberts et al. MRI of acute myocardial ischemia: Comparing a new contrast agent, Gd‐DTPA‐24‐cascade‐polymer, with Gd‐DTPA
JP4310187B2 (ja) Ｘ線と核磁気共鳴との組み合わせ診断法で使用するためのイオン性及び非イオン性ｘ線写真造影剤
ES2297888T3 (es) Procedimiento diagnostico para la deteccion de isquemia miocardica.
US12303572B2 (en) Ascorbate formulations and methods of use as contrast agents
CA2304461C (en) Lipophilic metal complexes for necrosis and infarction imaging
JP4614281B2 (ja) 磁気共鳴撮像方法並びに該方法に用いられる化合物
Kreft et al. Orally administered manganese chloride: enhanced detection of hepatic tumors in rats.
US5494656A (en) Second sphere complexes as relaxation agents for image enhancement in magnetic resonance imaging
US6495118B1 (en) Lipophilic metal complexes for necrosis and infarction imaging
Schuuring et al. Effect of breathing a hyperoxic hypercapnic gas mixture on the oxygenation of meningiomas; preliminary results
MXPA01004429A (en) Manganese compositions and methods for mri
Reimer Mangafodipir Trisodium “Teslascan”
AU2018201339B2 (en) Ascorbate formulations and methods of use as contrast agents
Yan et al. Pharmacokinetics and Bio-distribution of New Gd-complexes of DTPA-bis (amide)(L3) in a Rat Model
Bayrak et al. A comparison of low-dose and normal-dose gadobutrol in MR renography and renal angiography
Reimer Contrast Media MR, Organ Specific
Essig et al. Vasovist® in Brain Tumor Imaging

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R17-X000 Change to representative recorded

St.27 status event code: A-5-5-R10-R17-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20120227

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20130303

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20130303